{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:42:17Z","timestamp":1790224937393,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":652,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ajpath.2017.11.006","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T19:53:54Z","timestamp":1519934034000},"page":"574-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Inhibition of Marfan Syndrome Aortic Root Dilation by Losartan"],"prefix":"10.1016","volume":"188","author":[{"given":"Stephanie L.","family":"Sellers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Milad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayleigh","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mielnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Una","family":"Jermilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rini","family":"de Crom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy A.","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Sandor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Van Breemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Esfandiarei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Seidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Bernatchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2017.11.006_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/jmg.37.1.9","article-title":"The molecular genetics of Marfan syndrome and related microfibrillopathies","volume":"37","author":"Robinson","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.ajpath.2017.11.006_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000151766","article-title":"Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis","volume":"46","author":"Jones","year":"2009","journal-title":"J Vasc Res"},{"key":"10.1016\/j.ajpath.2017.11.006_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R","article-title":"Revised diagnostic criteria for the Marfan syndrome","volume":"62","author":"De Paepe","year":"1996","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ajpath.2017.11.006_bib4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1017\/S1047951100012907","article-title":"Current insights in diagnosis and management of the cardiovascular complications of Marfan's syndrome","volume":"12","author":"Nollen","year":"2002","journal-title":"Cardiol Young"},{"key":"10.1016\/j.ajpath.2017.11.006_bib5","first-page":"123","article-title":"A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment","volume":"129","author":"Halpern","year":"1971","journal-title":"Johns Hopkins Med J"},{"key":"10.1016\/j.ajpath.2017.11.006_bib6","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJM197204132861502","article-title":"Life expectancy and causes of death in the Marfan syndrome","volume":"286","author":"Murdoch","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2017.11.006_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2017.11.006_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2017.11.006_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cjca.2015.11.003","article-title":"Recent clinical drug trials evidence in Marfan syndrome and clinical implications","volume":"32","author":"Singh","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ajpath.2017.11.006_bib10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jpeds.2014.07.008","article-title":"\u03b2-Blockers and angiotensin converting enzyme inhibitors: comparison of effects on aortic growth in pediatric patients with Marfan syndrome","volume":"165","author":"Phomakay","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajpath.2017.11.006_bib11","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2017.11.006_bib12","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan's syndrome","volume":"371","author":"Lacro","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2017.11.006_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.1192152","article-title":"Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism","volume":"332","author":"Habashi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2017.11.006_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI46215","article-title":"Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice","volume":"122","author":"Podowski","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2017.11.006_bib15","first-page":"1329","article-title":"Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome","volume":"124","author":"Cook","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2017.11.006_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bbrc.2012.12.110","article-title":"eNOS phosphorylation on serine 1176 affects insulin sensitivity and adiposity","volume":"431","author":"Kashiwagi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2017.11.006_bib17","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0002-9440(10)63524-9","article-title":"Functional expression of endothelial nitric oxide synthase fused to green fluorescent protein in transgenic mice","volume":"163","author":"van Haperen","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2017.11.006_bib18","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1172\/JCI44778","article-title":"A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice","volume":"121","author":"Bernatchez","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2017.11.006_bib19","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.2337\/db15-0472","article-title":"Direct eNOS activation provides atheroprotection in diabetes-accelerated atherosclerosis","volume":"64","author":"Sharma","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.ajpath.2017.11.006_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1465-9921-7-120","article-title":"Regional differences in the pattern of airway remodeling following chronic allergen exposure in mice","volume":"7","author":"Hirota","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.ajpath.2017.11.006_bib21","doi-asserted-by":"crossref","first-page":"e0164778","DOI":"10.1371\/journal.pone.0164778","article-title":"Aortic and cardiac structure and function using high-resolution echocardiography and optical coherence tomography in a mouse model of Marfan syndrome","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2017.11.006_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1073\/pnas.0407224102","article-title":"Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides","volume":"102","author":"Bernatchez","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2017.11.006_bib23","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1096\/fj.08-108316","article-title":"Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors","volume":"22","author":"Gembardt","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2017.11.006_bib24","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1073\/pnas.92.8.3521","article-title":"Regulation of blood pressure by the type 1A angiotensin II receptor gene","volume":"92","author":"Ito","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2017.11.006_bib25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.108.841981","article-title":"Circulating transforming growth factor-beta in Marfan syndrome","volume":"120","author":"Matt","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2017.11.006_bib26","first-page":"1331","article-title":"Angiotensin receptors in the cardiovascular system","volume":"18","author":"Wagenaar","year":"2002","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ajpath.2017.11.006_bib27","first-page":"e32","article-title":"Response to lack of specificity of commercial antibodies leads to misidentification of angiotensin type-1 receptor protein","volume":"61","author":"Herrera","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpath.2017.11.006_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/HYPERTENSIONAHA.112.203679","article-title":"Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein","volume":"61","author":"Herrera","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpath.2017.11.006_bib29","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/01.CIR.99.7.909","article-title":"Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation","volume":"99","author":"Wilson","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2017.11.006_bib30","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.bjp.0707181","article-title":"Endothelial dysfunction and compromised eNOS\/Akt signaling in the thoracic aorta during the progression of Marfan syndrome","volume":"150","author":"Chung","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ajpath.2017.11.006_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/416337a","article-title":"Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms","volume":"416","author":"Barouch","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2017.11.006_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jtcvs.2009.10.039","article-title":"Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome","volume":"140","author":"Yang","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ajpath.2017.11.006_bib33","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ijcard.2014.11.082","article-title":"A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes","volume":"179","author":"Sandor","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ajpath.2017.11.006_bib34","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1161\/CIRCRESAHA.108.174367","article-title":"Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9","volume":"102","author":"Chung","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2017.11.006_bib35","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/CIRCULATIONAHA.104.509760","article-title":"Losartan metabolite EXP3179 activates Akt and endothelial nitric oxide synthase via vascular endothelial growth factor receptor-2 in endothelial cells: angiotensin II type 1 receptor-independent effects of EXP3179","volume":"112","author":"Watanabe","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2017.11.006_bib36","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.RES.0000191538.76771.66","article-title":"Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells","volume":"97","author":"Saura","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2017.11.006_bib37","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1172\/JCI29877","article-title":"The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in\u00a0vivo","volume":"117","author":"Atochin","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2017.11.006_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nbt.2107","article-title":"Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility","volume":"30","author":"Cheung","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajpath.2017.11.006_bib39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nm.4266","article-title":"Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome","volume":"23","author":"Oller","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2017.11.006_bib40","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/ATVBAHA.112.300985","article-title":"Telmisartan exerts pleiotropic effects in endothelial cells and promotes endothelial cell quiescence and survival","volume":"33","author":"Siragusa","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2017.11.006_bib41","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/HYPERTENSIONAHA.109.138883","article-title":"Losartan metabolite EXP3179: an AT1-receptor-independent treatment strategy for patients with the metabolic syndrome","volume":"54","author":"Rossi","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpath.2017.11.006_bib42","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.bjp.0704956","article-title":"Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways","volume":"137","author":"Gelinas","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ajpath.2017.11.006_bib43","unstructured":"Napione LAM, Bussolino F: VEGF-mediated signal transduction in tumor angiogenesis. Physiologic and Pathologic Angiogenesis: Signaling Mechanisms and Targeted Therapy. Edited by Simionescu D, Simionescu A. London: InTech, 2017"},{"key":"10.1016\/j.ajpath.2017.11.006_bib44","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/CIRCULATIONAHA.109.927681","article-title":"Formation of plexiform lesions in experimental severe pulmonary arterial hypertension","volume":"121","author":"Abe","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2017.11.006_bib45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1752-1947-8-48","article-title":"Rupture of abdominal aortic aneurysm after intravitreal bevacizumab injection: a case report","volume":"8","author":"Baek","year":"2014","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.ajpath.2017.11.006_bib46","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI10259","article-title":"Inhibition of VEGF receptors causes lung cell apoptosis and emphysema","volume":"106","author":"Kasahara","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2017.11.006_bib47","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/CIRCRESAHA.116.310371","article-title":"The pathogenic transforming growth factor-\u03b2 overdrive hypothesis in aortic aneurysms and dissections: a mirage?","volume":"120","author":"Mallat","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2017.11.006_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.niox.2014.11.003","article-title":"Neuronal NOS localises to human airway cilia","volume":"44","author":"Jackson","year":"2015","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ajpath.2017.11.006_bib49","first-page":"L383","article-title":"Nitric oxide synthase isoform expression in the developing lung epithelium","volume":"276","author":"Sherman","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ajpath.2017.11.006_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vph.2009.10.005","article-title":"Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress","volume":"52","author":"Yang","year":"2010","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.ajpath.2017.11.006_bib51","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1476-5381.2009.00439.x","article-title":"Dysfunction of endothelial and smooth muscle cells in small arteries of a mouse model of Marfan syndrome","volume":"156","author":"Syyong","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ajpath.2017.11.006_bib52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/japplphysiol.00132.2017","article-title":"Mild aerobic exercise blocks elastin fiber fragmentation and aortic dilatation in a mouse model of Marfan syndrome associated aortic aneurysm","volume":"123","author":"Gibson","year":"2017","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.ajpath.2017.11.006_bib53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mayocp.2012.11.005","article-title":"Losartan added to beta-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study","volume":"88","author":"Chiu","year":"2013","journal-title":"Mayo Clin Proc"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944017305497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944017305497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T12:21:39Z","timestamp":1576239699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944017305497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0002944017305497"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2017.11.006","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Marfan Syndrome Aortic Root Dilation by Losartan","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2017.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}